We are live on ! Find out more
TEVA icon

Teva Pharmaceuticals
TEVA

744 hedge funds and large institutions have $16.6B invested in Teva Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 744 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.92% more ownership

Funds ownership: 0% → 44.92% (+45%)

11% more call options, than puts

Call options by funds: $268M | Put options by funds: $242M

Holders
744
Holders Change
+744
Holders Change %
–
% of All Funds
24.28%
Holding in Top 10
32
Holding in Top 10 Change
+32
Holding in Top 10 Change %
% of All Funds
1.04%
New
744
Increased
–
Reduced
–
Closed
–
Calls
$268M
Puts
$242M
Net Calls
+$25.9M
Net Calls Change
+$25.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PIA
76
Philadelphia International Advisors
Pennsylvania
$33M +$32.8M +842,396 New
Barclays
77
Barclays
United Kingdom
$32M +$31.8M +817,614 New
State Street
78
State Street
Massachusetts
$31.6M +$31.4M +807,251 New
Balyasny Asset Management
79
Balyasny Asset Management
Illinois
$31.5M +$31.3M +803,013 New
SNC
80
Stifel Nicolaus & Co
Missouri
$31M +$30.8M +790,865 New
CS
81
Credit Suisse
Switzerland
$30.6M +$30.4M +781,217 New
AAMU
82
Amundi Asset Management US
Massachusetts
$29.9M +$29.7M +762,471 New
CCM
83
Camber Capital Management
Massachusetts
$29.4M +$29.2M +750,000 New
TA
84
Teachers Advisors
New York
$29.4M +$29.2M +749,509 New
BM
85
Bridger Management
New York
$28.8M +$28.6M +735,000 New
Capital International Investors
86
Capital International Investors
California
$27.8M +$27.6M +710,000 New
MG
87
Markel Group
Virginia
$27.4M +$27.2M +699,000 New
TSW
88
Thompson Siegel & Walmsley
Virginia
$26.9M +$26.7M +685,088 New
GC
89
GMT Capital
Georgia
$25.2M +$25M +641,800 New
First Manhattan
90
First Manhattan
New York
$25M +$24.4M +626,088 New
Ninety One (UK)
91
Ninety One (UK)
United Kingdom
$24.4M +$24.3M +623,730 New
HI
92
Honeywell International
North Carolina
$23.9M +$23.8M +610,000 New
ERSOT
93
Employees Retirement System of Texas
Texas
$23.4M +$23.2M +596,953 New
WA
94
Wasatch Advisors
Utah
$22.9M +$22.8M +584,832 New
PTA
95
Pear Tree Advisors
Massachusetts
$21.4M +$21.2M +544,919 New
Public Sector Pension Investment Board (PSP Investments)
96
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$20.8M +$20.7M +530,460 New
BBHC
97
Brown Brothers Harriman & Co
New York
$20.7M +$20.6M +528,175 New
EPIM
98
Echo Point Investment Management
Pennsylvania
$20.7M +$20.5M +527,204 New
HP
99
Holowesko Partners
Bahamas
$20.3M +$20.2M +517,500 New
NTCOC
100
Northern Trust Company of Connecticut
Connecticut
$19.8M +$19.7M +505,773 New
2 3
4
5 6

TEVA Hedge Fund Activity: Q2 2013 in Review

744 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceuticals (TEVA) for Q2 2013, worth a combined $16.6B.

Buyers outnumbered sellers: 744 funds opened new TEVA positions and 0 closed out — a net gain of 744 holders — while 0 added to existing stakes and 0 trimmed.

  • 744 institutional investors held Teva Pharmaceuticals (TEVA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $16.6B of Teva Pharmaceuticals stock for Q2 2013.
  • 744 funds opened new Teva Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +744 holders.

Based on aggregated 13F filings for Q2 2013.